Background One Health approach is crucial to tackling complex global public health threats at the interface of humans, animals, and the environment. As outlined in the One Health Joint Plan of Action, the internationa...Background One Health approach is crucial to tackling complex global public health threats at the interface of humans, animals, and the environment. As outlined in the One Health Joint Plan of Action, the international One Health community includes stakeholders from different sectors. Supported by the Bill & Melinda Gates Foundation, an academic community for One Health action has been proposed with the aim of promoting the understanding and real-world implementation of One Health approach and contribution towards the Sustainable Development Goals for a healthy planet.Main text The proposed academic community would contribute to generating high-quality scientific evidence, distilling local experiences as well as fostering an interconnected One Health culture and mindset, among various stakeholders on different levels and in all sectors. The major scope of the community covers One Health governance, zoonotic diseases, food security, antimicrobial resistance, and climate change along with the research agenda to be developed. The academic community will be supported by two committees, including a strategic consultancy committee and a scientific steering committee, composed of influential scientists selected from the One Health information database. A workplan containing activities under six objectives is proposed to provide research support, strengthen local capacity, and enhance global participation.Conclusions The proposed academic community for One Health action is a crucial step towards enhancing communication, coordination, collaboration, and capacity building for the implementation of One Health. By bringing eminent global experts together, the academic community possesses the potential to generate scientific evidence and provide advice to local governments and international organizations, enabling the pursuit of common goals, collaborative policies, and solutions to misaligned interests.展开更多
<em>Background:</em> Antisense peptide nucleic acids (PNAs) exhibit growth inhibitory effects on bacteria by inhibiting the expression of essential genes and could be promising therapeutic agents for treat...<em>Background:</em> Antisense peptide nucleic acids (PNAs) exhibit growth inhibitory effects on bacteria by inhibiting the expression of essential genes and could be promising therapeutic agents for treating bacterial infections. A study was carried out to determine the efficacy of several antisense PNAs in inhibiting extracellular and intracellular growth of <em>Mycobacterium smegmatis</em>. <em>Methods: </em>Six PNAs obtained from a commercial supplier were tested to evaluate the inhibitory effect on bacterial growth by inhibiting the expression of the following essential genes: <em>inhA </em>(a fatty acid elongase), <em>rpsL</em> (ribosomal S12 protein), <em>gyrA</em> (DNA gyrase), <em>pncA</em> (pyrazinamidase), <em>polA</em> (DNA polymerase I) and <em>rpoC</em> (RNA polymerase <em>β</em> subunit) of <em>M. smegmatis</em>. Each PNA was tested at 20 μM, 10 μM, 5 μM and 2.5 μM concentrations to determine whether they caused a dose dependent killing of <em>M. smegmatis</em> cultured in Middlebrook 7H9 broth or in a J774A.1 murine macrophage cell line.<em> Results:</em> In Middlebrook broth, the strong growth inhibitory effect against <em>M. smegmatis</em> was observed by PNAs targeting the <em>inhA </em>and <em>rpsL</em> genes at all four concentrations. The PNAs targeting the<em> pncA</em>, <em>polA</em> and<em> rpoC</em> genes were found to exhibit strong growth inhibition against <em>M. smegmatis</em> but only at 20 μM concentration. No growth inhibition of <em>M. smegmatis </em>was seen in pure culture when treated with PNAs targeting gyrA and a mismatch PNA targeting dnaG (DNA primase). All six PNAs showed killing of <em>M. smegmatis </em>in J774A.1 macrophage cell line that were statistically significant (p < 0.05). <em>Conclusion:</em> It may be concluded from this study that PNAs could be potential therapeutics for mycobacterial infections.展开更多
Background Despite the increasing focus on strengthening One Health capacity building on global level,challenges remain in devising and implementing real-world interventions particularly in the Asia-Pacific region.Rec...Background Despite the increasing focus on strengthening One Health capacity building on global level,challenges remain in devising and implementing real-world interventions particularly in the Asia-Pacific region.Recognizing these gaps,the One Health Action Commission(OHAC)was established as an academic community for One Health action with an emphasis on research agenda setting to identify actions for highest impact.Main text This viewpoint describes the agenda of,and motivation for,the recently formed OHAC.Recognizing the urgent need for evidence to support the formulation of necessary action plans,OHAC advocates the adoption of both bottom-up and top-down approaches to identify the current gaps in combating zoonoses,antimicrobial resistance,addressing food safety,and to enhance capacity building for context-sensitive One Health implementation.Conclusions By promoting broader engagement and connection of multidisciplinary stakeholders,OHAC envisions a collaborative global platform for the generation of innovative One Health knowledge,distilled practical experience and actionable policy advice,guided by strong ethical principles of One Health.展开更多
文摘Background One Health approach is crucial to tackling complex global public health threats at the interface of humans, animals, and the environment. As outlined in the One Health Joint Plan of Action, the international One Health community includes stakeholders from different sectors. Supported by the Bill & Melinda Gates Foundation, an academic community for One Health action has been proposed with the aim of promoting the understanding and real-world implementation of One Health approach and contribution towards the Sustainable Development Goals for a healthy planet.Main text The proposed academic community would contribute to generating high-quality scientific evidence, distilling local experiences as well as fostering an interconnected One Health culture and mindset, among various stakeholders on different levels and in all sectors. The major scope of the community covers One Health governance, zoonotic diseases, food security, antimicrobial resistance, and climate change along with the research agenda to be developed. The academic community will be supported by two committees, including a strategic consultancy committee and a scientific steering committee, composed of influential scientists selected from the One Health information database. A workplan containing activities under six objectives is proposed to provide research support, strengthen local capacity, and enhance global participation.Conclusions The proposed academic community for One Health action is a crucial step towards enhancing communication, coordination, collaboration, and capacity building for the implementation of One Health. By bringing eminent global experts together, the academic community possesses the potential to generate scientific evidence and provide advice to local governments and international organizations, enabling the pursuit of common goals, collaborative policies, and solutions to misaligned interests.
文摘<em>Background:</em> Antisense peptide nucleic acids (PNAs) exhibit growth inhibitory effects on bacteria by inhibiting the expression of essential genes and could be promising therapeutic agents for treating bacterial infections. A study was carried out to determine the efficacy of several antisense PNAs in inhibiting extracellular and intracellular growth of <em>Mycobacterium smegmatis</em>. <em>Methods: </em>Six PNAs obtained from a commercial supplier were tested to evaluate the inhibitory effect on bacterial growth by inhibiting the expression of the following essential genes: <em>inhA </em>(a fatty acid elongase), <em>rpsL</em> (ribosomal S12 protein), <em>gyrA</em> (DNA gyrase), <em>pncA</em> (pyrazinamidase), <em>polA</em> (DNA polymerase I) and <em>rpoC</em> (RNA polymerase <em>β</em> subunit) of <em>M. smegmatis</em>. Each PNA was tested at 20 μM, 10 μM, 5 μM and 2.5 μM concentrations to determine whether they caused a dose dependent killing of <em>M. smegmatis</em> cultured in Middlebrook 7H9 broth or in a J774A.1 murine macrophage cell line.<em> Results:</em> In Middlebrook broth, the strong growth inhibitory effect against <em>M. smegmatis</em> was observed by PNAs targeting the <em>inhA </em>and <em>rpsL</em> genes at all four concentrations. The PNAs targeting the<em> pncA</em>, <em>polA</em> and<em> rpoC</em> genes were found to exhibit strong growth inhibition against <em>M. smegmatis</em> but only at 20 μM concentration. No growth inhibition of <em>M. smegmatis </em>was seen in pure culture when treated with PNAs targeting gyrA and a mismatch PNA targeting dnaG (DNA primase). All six PNAs showed killing of <em>M. smegmatis </em>in J774A.1 macrophage cell line that were statistically significant (p < 0.05). <em>Conclusion:</em> It may be concluded from this study that PNAs could be potential therapeutics for mycobacterial infections.
基金supported in whole by the Bill&Melinda Gates Foundation(No.INV-046218)
文摘Background Despite the increasing focus on strengthening One Health capacity building on global level,challenges remain in devising and implementing real-world interventions particularly in the Asia-Pacific region.Recognizing these gaps,the One Health Action Commission(OHAC)was established as an academic community for One Health action with an emphasis on research agenda setting to identify actions for highest impact.Main text This viewpoint describes the agenda of,and motivation for,the recently formed OHAC.Recognizing the urgent need for evidence to support the formulation of necessary action plans,OHAC advocates the adoption of both bottom-up and top-down approaches to identify the current gaps in combating zoonoses,antimicrobial resistance,addressing food safety,and to enhance capacity building for context-sensitive One Health implementation.Conclusions By promoting broader engagement and connection of multidisciplinary stakeholders,OHAC envisions a collaborative global platform for the generation of innovative One Health knowledge,distilled practical experience and actionable policy advice,guided by strong ethical principles of One Health.